Article
Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.
Seminars in thrombosis and hemostasis - 1 Feb 2017
Woods Adriana Ines, Kempfer Ana Catalina, Paiva Juvenal, Sanchez-Luceros Analia, Bermejo Emilse, Chuit Roberto, Alberto Maria Fabiana, Blanco Alicia Noemi, Lazzari Maria Angela
Abstract excerpt
von Willebrand disease type 2B (VWD2B) expresses gain-of-function mutations that enhance binding of an individual's von Willebrand factor (VWF) to its platelet ligand, glycoprotein Ib (GPIb), and which are usually identified by increased ristocetin-induced platelet aggregation (RIPA). We describe here the phenotypic profile of 38 genotypically selected VWD2B-affected family members (AFMs) belonging to 19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
